In addition, The Enhanced Control of Hypertension and Thrombolysis Stroke Study with 63% Asian patients did not demonstrate the non-inferior effect of 0.6–0.9 mg/kg r-tPA in Asians, but showed comparable effectiveness outcomes in some subgroups (11). The gene discussed is PLAT; the disease is Hypertension.